Please Wait
Applying Filters...
menu
    • menu
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Gallium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RadioMedix Gets FDA Approval for Generic Ga-68 PSMA-11
    RadioMedix Gets FDA Approval for Generic Ga-68 PSMA-11

    10 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/10/3309646/0/en/radiomedix-announces-receiving-fda-approval-of-its-generic-ga-68-psma-11-radiodiagnostic-for-prostate-cancer.html

    GLOBENEWSWIRE
    10 Jun 2026
    Share Share
    Radiomedix’s Generics Gallium Gozetotide Receives Approval in US
    Radiomedix’s Generics Gallium Gozetotide Receives Approval in US

    08 Jun 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216410

    FDA
    08 Jun 2026
    Share Share
    Ionetix Gets ANDA Approval for Ga-68 Gozetotide (PSMA-11)
    Ionetix Gets ANDA Approval for Ga-68 Gozetotide (PSMA-11)

    26 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/26/3301225/0/en/ionetix-announces-approval-of-abbreviated-new-drug-application-for-gallium-ga-68-gozetotide-psma-11.html

    GLOBENEWSWIRE
    26 May 2026
    Share Share
    Telix Collab to Explore PSMA-PET in Prostate Cancer Treatment
    Telix Collab to Explore PSMA-PET in Prostate Cancer Treatment

    15 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/15/3295677/0/en/telix-announces-collaborations-to-explore-psma-pet-imaging-in-emerging-prostate-cancer-treatment-approaches.html

    GLOBENEWSWIRE
    15 May 2026
    Share Share
    Ionetix’s Generics Gallium Gozetotide Receives Approval in US
    Ionetix’s Generics Gallium Gozetotide Receives Approval in US

    14 May 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219189

    FDA
    14 May 2026
    Share Share
    First U.S. Patient Dosed In BiPASS Phase 3 Prostate Cancer Study
    First U.S. Patient Dosed In BiPASS Phase 3 Prostate Cancer Study

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220521/0/en/First-U-S-Patient-Dosed-in-BiPASS-Phase-3-Prostate-Cancer-Diagnosis-Study.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.